George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Hulver - good post ,
Prevail ain’t no naive muppets , they are a professional organisation who backed Hemos science & tossed a wedge in a lot higher than current stock price ,
I’m sure Vlad & Prevail are investigating all potential avenues for the benefit of Hemo & stockholders including Prevail .
Noted by Prevail in Sept RNS
Mary Schaheen, President of Prevail Partners, stated: "Everyone at our fund is confident in the growth and success of Hemogenyx Pharmaceuticals as they develop CAR-T cells to target acute myeloid leukemia. Furthermore, Hemogenyx Pharmaceuticals has a seasoned management team with the expertise to accelerate the company to a significant value inflection point through the completion of its planned clinical trial."
Let’s see what next few months bring
A lot of disgruntled investors on here of late
Stock price has been stuck between 1.55 @ 1.7 for weeks since placement
Volume is very low of late
3 million today
The stock certainly won’t motor north with thin volume , & purely trading water until news arrives .
However will motor north when further news on clinical is announced or a pharma deal with help from Prevail , imo
To note -
Stock on loan / shorts
Current 4.3 million
a 200 k short was opened Tuesday , I would guess a chancer hoping for bad news within the results
& a 4.2 million short was opened 2 days after placement news @1.62
So i am sceptical on any stock & any forums with negativity been posted with recent shorts opened , very risky in Hemo’s current position imo
Hemo are clinical & working with Prevail on CAR T
With CBR & CDX cooking
Good products will attract financial pharmas once news is confirmed. Imo
Morning all invested
RNS - does what it says on the tin
Not a stock mover .
Highlights the science continues development -
CAR T clinical
Underpinned by Prevail
Cash in the bank
CBR & CDX plenty of info on these developments & huge potential
Let’s see what next few months bring - I’m sure Vlad & Prevail aren’t sat twiddling their thumbs
All invested have choices - buy - hold - sell
I’m very content to let all Hemo science unfold & stock re rate - especially from current levels
Dry powder level imo the science is developing & a nice juicy pharma deal would suffice .
Morning All
Stock continues to fluctuate between 1.6- 1.7 until volume increases or an RNS drops …
Plenty of bed & isa trades over recent sessions .
Hemo is in a very strong position vs potential returns imo .especially from current levels ,
Re - read recent RNS & Vlads interview …
cash raised -
- clinical on CAR T -
- zero debt
- underpinned by prevail
- multi pronged science - CBR , CDX
Let’s see what next month brings - Vlads certainly quiet , perhaps at present busy turning those CAR T cogs with Prevail no doubt & any whiff of a pharma deal / partnership & the stock price will be Broadsided imo
The science continues
morning all actual stockholders
second that ****nalles great work jaygee , & shows there are mining pans simmering in the shadows of the war .
all invested await a whiff of potential asset sale .
this board is almost unreadable of late half a dozen crackpots goading any investor who actually mentions eua & arguing over war situation & political agenda ,
yet probably the nearest to any military action any of them got was level 3 on cod 👎
even septic lil is bored with these reincarnated keyboard bots .
green energy boom / asset sale of precious metals vs war situation / political battlefield
Vol 11.5 million
Need stronger vol to move north however a positive RNS update would suffice ..
Someone’s tossed a wedge in - nice kipper buy
18-Apr-24 16:00:11 1.684 1,500,000 Buy* 1.612 1.644 25.26k
Afternoon all invested
Good to see a new website for sure .
The stock will re rate when news flows , however we require volume been dryer than an Arizona creek in last week .
Clinical & plenty of cash with CBR & CDX simmering has huge potential from current levels imo
Afternoon all invested
Stagnant in thin volume awaiting updates .
3.3 million
To note -
Stock on loan / shorts
4.2 million -
Dropped 600 k yesterday- short closed
Cost to borrow- 15
Irrespective of daily market shenanigans,
Hemos science cogs keep turning & the stock will re rate when clinical news flows imo .
At current levels investors nibble fingers & use dry powder .
Recent Rns & article on Hemo very positive for the future.
Afternoon all
To note -
Stock on loan / shorts
4.75 million
4.2 million opened 2 weeks ago @ 1.6 - costing money to keep open & making nowt - unlucky
a 500k short was opened yesterday
Perhaps attached to some of the negativity on here , who knows who cares ,
Current stock price 1.61 - + blue -
Vol - 6.3 million - thin
Let’s all invested hope a decent RNS drops & gets this clinical party started .
The recent article posted about Hemo was certainly loaded with potential for investors .
Let’s see what next few weeks bring
Haywain & all
Great article , thanks for posting dude . 👍👍
These parts as many stand out for sure …
Upfront payments, usually a good litmus test of 'real' interest from these titans of the world of drugs, have been eye-watering; in some cases up to $100 million.
Hemogenyx will look to further non-dilutive funding to assess a cohort of around 18 AML sufferers, which will take it to the phase II stage of the clinical evaluation.
‘This is key, as it is the point that big pharma has weighed into the sector with the deals mentioned above.’
& this part is also mouth watering on CBR etc
"We are talking to institutions and agencies," Sandler says. "There is a lot of interest and we are moving these conversations along."
The Ice Age-like big freeze across the small-cap market in the UK means none of company's potential has been captured in the current share price, which values Hemogenyx at a bargain basement £21 million.
If we accept this is a cyclical anomaly, the rebound could be dramatic - not just for the sector, but individual stocks such as Hemogenyx.
Let’s see what next few months bring …for all invested .
Evening all invested
Cheers to Ray , Brox, Lenoman & others for posting the account details ,
Sold a few quids worth of product 👍
( at least they didn’t use Everton’s accountants # cooking the books again )
Stock on loan / shorts
Current - 620 k
Cost to borrow 50
In a nutshell
Green Energy boom / precious metal world demand Vs War situation/ economic climate
Hence investors await news on potential asset sale -
or the crazy bald Russian gets taken out by one of Kim Jong un dodgy oversized missiles , he clearly has an unhealthy obsession with huge missiles due to having tiny genitalia .
To note ..
Still seems a lot of Turd flies loitering on deck considering they supposedly have nowt down for this stock , company & war been raging 2 yr .. perhaps obsessed with this board like Kim Jong un is with large ballistic weapons .
Rums &sell the product all Round
Delayed kippers landing before the bell
Buys , sells , Rollovers , whatever - all on the median - still hefty lumps
08-Apr-24 14:27:21 1.62 6,000,000 Unknown* 1.61 1.636 97.20k O
08-Apr-24 14:27:12 1.60 6,000,000 Unknown* 1.61 1.636 96.00k O
08-Apr-24 15:15:27 1.60 1,650,000 Unknown* 1.61 1.636 26.40k
Hemo cogs keep turning & news will land …
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
They you go ladies & Gents
A bit of positivity & she’s in Blue waters
1.7 paid
08-Apr-24 15:27:11 1.6576 250,000 Buy* 1.62 1.682 4,144 O
08-Apr-24 15:26:58 1.6613 298,872 Buy* 1.62 1.682 4,965 O
08-Apr-24 15:26:22 1.6586 250,000 Buy* 1.62 1.696 4,147 O
08-Apr-24 15:26:20 1.70 963 Buy* 1.62 1.696 16.37 O
Let’s see what next few months bring to Hemo investors
Come on troops , Frustration creeping in when the stock is lacklustre ,
However , if a pharma deal was announced on clinical & the stock shot to 10p , many would then wish they had purchased more at the current level .
That’s the markets for you , however Hemo is in a very strong position vs potential returns imo .especially from current levels ,
Re - read recent RNS & Vlads interview …
yet cash raised -
- clinical on CAR T -
- zero debt
- underpinned by prevail
- multi pronged science - CBR , CDX
Let’s see what next month brings - Vlads certainly quiet , perhaps at present busy turning those CAR T cogs with Prevail no doubt & any whiff of a pharma deal / partnership & the stock price will be Broadsided imo
Let’s see what next few months bring
Another 8.5 million trade showing delayed from 8am - it matches one of the earlier 8.5 mil trades - same time stamp
Perhaps another due to land to match other so double roll over or perhaps the roll theory flushed down the karzy -
Number 3 - 8.5 million trade
05-Apr-24 08:00:22 1.70 -8,500,000 Unknown* 1.61 1.64 -144.50k O
I will await the smart ass answers riddled with condescending tone …
Shorts only showing 4.2 million on loan .